Back | Next |
home / stock / nbio / nbio message board
Subject | By | Source | When |
---|---|---|---|
Spread just tightened $NBIO | Robertscott | investorshub | 07/11/2023 2:38:35 PM |
$NBIO Nascent Biotech Phase I Clinical Data Presented | jedijazz | investorshub | 07/11/2023 2:20:15 PM |
.05's super thin | budfoxfun | investorshub | 07/11/2023 2:19:11 PM |
Low floater, won't take much here for a breakout! | budfoxfun | investorshub | 07/11/2023 2:03:21 PM |
$NBIO is in the course of its development | jedijazz | investorshub | 07/11/2023 2:01:45 PM |
Why $NBIO is a Biotech Bargain Basement Deal | jedijazz | investorshub | 07/11/2023 2:00:50 PM |
Looking thin this morning $NBIO | Robertscott | investorshub | 07/11/2023 1:32:49 PM |
This is when new star drug assets have | Robertscott | investorshub | 07/11/2023 1:32:19 PM |
.05 ready to go! | budfoxfun | investorshub | 07/11/2023 1:17:45 PM |
The share price of a stock isn't a | Robertscott | investorshub | 07/11/2023 1:03:11 PM |
$NBIO Nascent Biotech Inc. is an emerging player | Robertscott | investorshub | 07/11/2023 1:02:21 PM |
Nascent Biotech Inc. $NBIO is an emerging player | budfoxfun | investorshub | 07/11/2023 12:59:15 PM |
after the ASCO 2023 Poster reveal, BioRay ditched | LearningEveryTrade | investorshub | 06/14/2023 1:27:44 PM |
15 patients in recent clinical trial and One | Aa5 | investorshub | 06/12/2023 6:01:03 PM |
Thank you, good luck to you and everyone here. $NBIO | BlazingStocks | investorshub | 06/12/2023 12:47:00 PM |
1st buy after selling on that big move | FairviewInvestor | investorshub | 06/09/2023 6:13:58 PM |
One partial response showed nearly a 98.0% and | Aa5 | investorshub | 06/08/2023 4:11:06 PM |
I agree. I have shares. I | gladeshawk | investorshub | 06/08/2023 3:25:00 PM |
It's a great opportunity to load at these | BlazingStocks | investorshub | 06/08/2023 3:19:49 PM |
I have bids in down into the .03s. | gladeshawk | investorshub | 06/08/2023 3:09:09 PM |
News, Short Squeeze, Breakout and More Instantly...
NORTH PALM BEACH, FL / ACCESSWIRE / April 16, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, announces that it is embarking on a fresh manufacturin...
NORTH PALM BEACH, FL / ACCESSWIRE / March 19, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, and HypoSpray Pharma ("HypoSpray ® "), a clinical...
NORTH PALM BEACH, FL and NEW YORK, NY / ACCESSWIRE / February 6, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent"), a clinical-stage biotechnology company pioneering the development of monoclonal antibodies for the treatment of various cancers and viral infections, announc...